. Moreover, 2i treatment promotes the derivation of ES cells in rodents and possibly other mammals in vitro [10][11][12] . Nevertheless, the quality and stability of 2i-established ES cells still remains to be fully elucidated.
Mouse ES cells derived from the inner cell mass (ICM) of preimplantation embryos exhibit pluripotency that is shared with ICM cells in vivo. Culture media supplemented with fetal bovine serum (FBS) have been used for the derivation and maintenance of ES cells. However, ES cells in serum display heterogeneity and fluctuate between naive ICM-like state and primed epiblast-like state 3 . Notably, the inhibition of Mek1/2 and Gsk3β (2i) maintains ES cells in a more homogenous naive ground state 4 . Consistently, 2i-treated ES cells show global transcriptional profiles reminiscent of ICM cells with reduced DNA methylation [5] [6] [7] [8] [9] . Moreover, 2i treatment promotes the derivation of ES cells in rodents and possibly other mammals in vitro [10] [11] [12] . Nevertheless, the quality and stability of 2i-established ES cells still remains to be fully elucidated.
To explore the epigenetic and functional properties of 2i-established ES cells, we derived mouse ES cells from F 1 (129X1/SvJ and MSM/Ms) blastocysts in which their parental alleles are distinguishable by a large number of single nucleotide polymorphisms (SNPs) 13 . The genetically matched ES cells were established under one of two culture conditions, serum plus leukaemia inhibitory factor (LIF) (S/L) or 2i plus LIF (2i/L), and early passaged ES cells (passage number 3, p3) were used for further molecular analyses (Fig. 1a) . We first carried out quantitative analysis of genome-wide DNA methylation of S/L and 2i/L ES cells (Extended Data Fig. 1 ). Consistent with previous studies 5, 6 , 2i treatment induced a significant and widespread reduction of DNA methylation in ES cells that was more prominent in female ES cells (Fig. 1b and Extended Data Fig. 2a, b ) 6, 7, 14, 15 . We confirmed that early-passage female 2i/L ES cell lines (p3) maintain normal karyotypic patterns (Extended Data  Fig. 2c ).
In contrast to previous reports [5] [6] [7] [8] , DNA methylation levels at ICRs and intracisternal A particles (IAPs) were markedly decreased in 2i/L ES cells (p3; Fig. 1c, d ). The reduction of global and ICR methylation levels was detected even at p1 (Extended Data Fig. 2d ). We next performed allelic analysis of the DNA methylation, which includes imprints ( Fig. 1e and Extended Data Fig. 2e, f ) . Notably, DNA methylation at ICRs had already been eroded in male 2i/L ES cells and almost erased in female 2i/L ES cells at p3 ( Fig. 1e and Extended Data Fig. 3a-c) . Consistent with the reduction of ICR methylation, both male and female 2i/L ES cells showed biallelic expression of imprinted genes ( Fig. 1f and Extended Data Fig. 3d ). Collectively, we conclude that 2i/L ES cells exhibit defects in genomic imprints.
Because female 2i/L ES cells lack most DNA methylation, we next investigated the dynamics of DNA methylation in female 2i/L ES cells after exposure to S/L for 28 days (2i/L-S/L ES cells; Fig. 2a ). 2i/L-S/L ES cells (p14) exhibited a substantial increase in global DNA methylation (Fig. 2b, c) . Despite genome-wide erasure of DNA methylation, 2i/L ES cells formed teratomas and efficiently contributed to a wide variety of cells in E14.5 embryos ( Fig. 2d and Extended Data Fig. 3e, f) . We then obtained 2i/L-ES cell-derived mouse embryonic fibroblasts (2i/L-MEFs) (p5; Fig. 2a ) and analysed global DNA methylation patterns. We observed a further gain of de novo DNA methylation in 2i/L-MEFs (Extended Data Fig. 3g ), suggesting that female 2i/L ES cells efficiently contribute to chimaeric embryos as they undergo de novo methylation during development. As DNA methylation is essential for normal development 16 , 2i/L ES cells with Dnmt1 knocked out or a double knockout of both Dnmt3a and Dnmt3b ceased to grow upon the induction of differentiation and did not contribute to E14.5 embryos at all (Extended Data Fig. 4 and Supplementary Fig. 1 ), demonstrating that de novo and maintenance methylation are essential for the differentiation of 2i/L ES cells.
Importantly, de novo methylation was not observed at ICRs in either 2i/L-S/L ES cells or 2i/L-MEFs ( Fig. 2e and Extended Data Fig. 5a, b) , which is consistent with the previous finding that ES cells and somatic cells lack the ability to restore imprints [17] [18] [19] . We also detected biallelic expression of imprinted genes in both 2i/L-S/L ES cells and 2i/L-MEFs ( Fig. 2f and Extended Data Fig. 5c ). Apart from ICRs, most oocyte/ sperm differentially methylated regions (DMRs) gained de novo methylation in 2i/L-S/L ES cells and 2i/L-MEFs (Extended Data Fig. 5d ). Notably, secondary DMRs often gained aberrant de novo methylation in 2i/L-MEFs, demonstrating that despite efficient contribution to embryos, 2i/L-MEFs harbour abnormal DNA methylation patterns in conjunction with the loss of ICR methylation (Extended Data Fig. 5e, f) .
As reported previously 2 , we found that 2i/L ES cells are consistently able to form chimaeric embryos that exhibit a high contribution of ES-cell-derived cells (Extended Data Fig. 6a ). Considering that aberrant imprinting is often linked to abnormal development and various diseases 17,20-22 , we next tested whether 2i/L ES cell nuclei have the autonomous potential for full-term development using somatic cell nuclear transfer (p4-p5; Fig. 3a ) 23 . 2i/L and S/L ES cell nuclei, both of which have normal karyotypes, were competent for early development into 2-cell-stage embryos at high percentages (Extended Data Fig. 6b ). However, cloned embryos from 2i/L ES cell nuclei often exhibited growth retardation around embryonic day 10.5 (Extended Data Fig. 6c) , and cloned pups were exclusively obtained from S/L ES cell nuclei ( Fig. 3b and Extended Data Fig. 6d) . Similarly, the placentae from 2i/L-ES-cell-cloned embryos (E10.5) often exhibited hypoplasia of the labyrinth layer and focal necrosis ( Fig. 3c and Extended Data Fig. 6e) . Notably, the 2i/L-ES-cell-cloned placentae often showed impaired cellular adhesion with reduced expression of membranous E-cadherin (Extended Data Fig. 6f ), which phenocopies trophectoderm cells lacking maternal DNA methylation 24 . To confirm the developmental defects of 2i/L ES cells with an independent assay, we next performed tetraploid embryo complementation using 2i/L and S/L ES cells (p5-p7; Fig. 3a ) 25 . As shown in Fig. 3d and Extended Data Fig. 6g , h, full term all-ES-cell mice were only obtained from S/L ES cells. Collectively, these results indicate that female 2i/L ES cells lacking heritable DNA methylation harbour impaired autonomous developmental potential.
To gain molecular insights into the developmental defects of 2i/L ES cell nuclei, we next employed the Cdx2-mediated trophectoderm differentiation protocol on ES cells 26 . After Cdx2 overexpression, the formation of trophoblast stem cell (TSC)-like colonies was severely impaired in 2i/L ES cells (Extended Data Fig. 7a, b) . Of note, Scml2, the suppression of which by maternal DNA methylation plays a role in proper placental development 24 , was derepressed in 2i/L ES cells (Extended Data Fig. 7c-f) . Finally, we found that the impaired TSC-like colony formation in Cdx2-induced 2i/L ES cells is 
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Nespas Gnas1A ; Extended Data Fig. 7g, h ). Collectively, these results suggest that the derepression of Scml2 is involved in abnormal placental development in 2i/L-EScell-cloned embryos, which is similarly observed in embryos deficient in maternal DNA methylation 24 . We also compared DNA methylation and gene expressions of 2i/L-MEFs derived from all-ES-cell embryos (4n 2i/L-MEFs; E14.5) with those from chimaeric embryos (2n 2i/L-MEFs; E14.5). Although no detectable difference in DNA methylations was observed between 4n 2i/L-MEFs and 2n 2i/L-MEFs (Extended Data Fig. 7i ), many imprinted genes, as well as other genes, were aberrantly expressed in 4n 2i/L-MEFs, whereas the aberration was less obvious in 2n 2i/L-MEFs, presumably owing to non-cellautonomous effects (Extended Data Fig. 7j ). Together, our results show that loss of gamete-derived methylation is associated with impaired autonomous development of 2i/L ES cells.
Considering Whole genome ICR These data suggest that modified culture conditions, particularly a2i/L conditions, preserve the epigenetic stability of genomic imprints and developmental potential of early-passage female ES cells. However, after prolonged culture, female a2i/L ES cells, as well as female t2i/L ES cells, at p15 showed a reduction of ICR methylation, which was similarly observed in S/L ES cells at p15, while male a2i/L ES cells at p15 retained ICR methylation ( Fig. 4f and Extended Data Fig. 9a, b) . In addition, reduction of Uhrf1 protein, as well as Dnmt3a and Dnmt3b proteins 14, 15 , was observed in female a2i/L ES cells (p3; Fig. 4g, Extended Data Fig. 9c, d and Supplementary Fig. 1 ), suggesting that impaired maintenance of DNA methylation leads to ICR demethylation in female a2i/L ES cells. As reported recently 15 , neither XO ES cells nor XX MEFs exhibit reduced levels of Uhrf1, indicating that two active X chromosomes cause the reduced expression of Uhrf1 (Extended Data Fig. 9d-g and Supplementary Fig. 1) .
In contrast to the decreased ICR methylation, we found that genomewide DNA methylation was increased in female a2i/L ES cells at p15 (Extended Data Fig. 10a) . Similarly, female 2i/L ES cells at p15 showed increased global DNA methylation compared with early-passage 2i/L ES cell lines (p3; Extended Data Fig. 10a ), which indicates that female 2i/L and a2i/L ES cells gained de novo methylation during prolonged culture. Consistently, the protein levels of Uhrf1 and Dnmt3b were higher in p15 female 2i/L and a2i/L ES cells than at p3 (Extended Data  Fig. 10b , c and Supplementary Fig. 1 ). Notably, we found that female ES cells at p15 display a loss of X chromosome to varying degrees (Extended Data Fig. 10d, e) , suggesting that the loss of two active X chromosomes causes, at least in part, increased Uhrf1 and Dnmt3b at p15.
These results, taken together, show that the derivation of ES cells under 2i/L results in a widespread reduction of DNA methylation, including gamete-derived methylation. These ES cells exhibit impairment in embryonic and placental development, which reveals the limitations of 2i/L-established ES cells for the quality of pluripotent stem cells. Our findings are important for the understanding of human naive-like pluripotent stem cells with regards to therapeutic applications and disease modelling, since imprints and oocyte-derived methylation memory are often lost in these cells 19, 30 . We also show that early-passage female a2i/L ES cells and t2i/L ES cells retain gametederived DNA methylation and autonomous developmental potential. We propose that these ES cells may serve as an alternative cell-culture platform for dissecting the biology of early embryogenesis.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 31 or 129X1/SvJ and C57BL/6) were obtained by in vitro fertilization (IVF). Cells were maintained at 37 °C with 5% CO 2. MEFs were isolated from E14.5 embryos and were cultured in DMEM (Nacalai Tesque) with 2 mM l-glutamine (Nacalai Tesque), 100 × non-essential amino acids (NEAA) (Nacalai Tesque), 100 U ml −1 penicillin, 100 μ g ml −1 streptomycin (P/S) (Nacalai Tesque) and 10% fetal bovine serum (FBS) (GIBCO). S/L cells were established and maintained on feeders (mitomycin C-treated MEFs) in knockout DMEM (GIBCO) with 2 mM l-glutamine, 100 × NEAA, P/S, 15% FBS, 0.11 mM β -mercaptoethanol (GIBCO) and 1,000 U ml −1 human recombinant leukaemia inhibitory factor (LIF) (Wako). For the establishment of S/L ES cells, a blastocyst was placed on feeders in 24-well plates (passage number 0: p0). After the expansion of ICM, the cells were passaged into 24-well plates (p1), followed by a second passage into 6-well plates (p2) and then a third passage into 6-cm dishes (p3). For the derivation of 2i/L ES cells, t2i/L ES cells and a2i/L ES cells, blastocyst was placed on feeders in 24-well plates with knockout DMEM containing 2 mM l-glutamine, 100 × NEAA, P/S, 15% FBS, 0.11 mM β -mercaptoethanol and 1,000 U ml −1 LIF, which was supplemented with 1 μ M PD0325901 (STEMGENT) and 3 μ M CHIR99021 (STEMGENT) for 2i/L, 0.2 μ M PD0325901 and 3 μ M CHIR99021 for t2i/L, and 1.5 μ M CGP77675 (Sigma) and 3 μ M CHIR99021 for a2i/L (p0). After passage into 24-well plates (p1), the cells were maintained without feeders in DMEM/ F12 (GIBCO) and Neurobasal (GIBCO) supplemented with B27 (GIBCO) and N2 cell-supplements (GIBCO), P/S, 2 mM Glutamax (GIBCO), and 1,000 U ml . C57BL/6, 129X1/SvJ, B6D2F1, BALB/c, C3H/He, DBA/2, ICR mice, pseudo-pregnant ICR mice and BALB/cSlc-nu/nu mice were purchased from SLC. Noon of the day when the plug was observed was designated as embryonic day (E) 0.5. Cell line availability. The Dnmt triple-knockout ES cell line was obtained from RIKEN Bio Resource Center (RBRC-AES0146) 32 . Other cell lines were derived in our laboratory and tested for mycoplasma contamination. G418 Disulfate Aqueous Solution (Nacalai tesque). GFP-positive colonies were picked up and established as GFP-labelled clones (p5). DNA/RNA extraction and cDNA synthesis. DNA was extracted by PureLink Genomic DNA Mini Kit (Invitrogen) and RNA was extracted by RNAeasy plus Mini Kit (QIAGEN). DNA and RNA were quantified by Nanodrop 2000c (Thermo Scientific) and Qubit (Thermo Scientific). Reverse transcription was performed with PrimeScript II 1st strand cDNA Synthesis Kit (Takara) according to the supplier's instruction. Quantitative RT-PCR. Quantitative PCR was performed using GoTaq qPCR Mater Mix and CXR Reference Dye according to the supplier's instruction (Promega).
StepOnePlus Real-Time PCR system (Applied Biosystems) was used. Transcript levels were normalized to β -actin (Actb). The experiments were performed in technical triplicates. The primers used for were: Scml2 forward: TGATTCGGTGTGTG TTGCTTC; Scml2 reverse: AGTCGTAGACGTAACCTGGCT; Dusp6 forward: ATAGATACGCTCAGACCCGTG; Dusp6 reverse: ATCAGCAGAAGC CGTTCGTT; Cldn7 forward: GGCCTGATAGCGAGCACTG; Cldn7 reverse: GTGACGCACTCCATCCAGA; Actb froward: GCCAACCGTGAAAAGATGAC; and Actb reverse: TCCGGAGTCCATCACAATG. Western blot. Cells were harvested in 500 μ l of RIPA lysis buffer containing protease inhibitor cocktail (Nacalai Tesque), dithiothreitol (wako) and phosphatase inhibitor cocktail (Nacalai Tesque). For S/L ES cells, we removed feeders by culturing dissociated ES cells in S/L medium for 30 min and harvesting floating cell populations. Proteins were denatured with 2 × SDS at 95 °C for 5 min. A total of 30 μ g denatured protein was run on 8% or 10% SDS-PAGE gel and transferred to Amersham Hybond-P PVDF Membrane (GE Healthcare) using PowerPac HC (Bio-Rad). Membranes were blocked with 4% skim milk (Nacalai Tesque) in 1 × TBS with 0.05% Tween-20 (TBST) and then incubated with primary antibodies diluted by blocking buffer (4% skim milk in TBST) overnight at 4 °C. The primary antibodies used were anti-phospho-p44/42 MAPK (CST, 20G11, 4376; dilution 1:1,000), anti-p44/42 MAPK (CST, L34F12, 4696S; dilution 1:2,000), anti-Dnmt3a (Novus Biological, NB120-13888, 64B1446; dilution 1:500; Santa Cruz, sc-20703; dilution 1:200), anti-Dnmt3b (Activemotif, 39207, 52A1018; dilution 1:125 / IMAGENEX, IMG-184A; dilution 1:500), anti-Dnmt3l (Abcam, ab3493; dilution 1:2,500), anti-Dnmt1 (COSMO BIO, 70-201EX; dilution 1:1,000), anti-Uhrf1 (Santa Cruz, sc-373750; dilution 1:100) and anti-β -actin (Santa Cruz, sc-47778; dilution 1:1,000). Blots were rinsed with TBST. Membranes were incubated with HRP-conjugated secondary antibodies for 90 min at room temperature. The secondary antibodies used were ECL anti-mouse IgG, HRP-linked whole antibody from sheep (NA931V, GE Healthcare) and ECL anti-rabbit IgG, HRP linked whole antibody from donkey (NA934V, GE Healthcare). After rinsing with TBST, Pierce ECL plus Western Blotting Substrate (Thermo Scientific) was used for visualization, and LAS4000 (GE Healthcare) was used for band detection. Immunocytochemistry. Cells were fixed with 4% paraformaldehyde (Wako) for 15 min and were treated with PBS (Nacalai tesque) containing 0.5% Triton (Sigma) for 5 min at room temperature. Cells were then treated with PBS containing 3% FBS and 0.1% Triton and stained with anti-5mC antibody (Diagenode, Mab-006-100; dilution 1:500) overnight at 4 °C. Secondary antibodies conjugated with Alexa Fluor 488 (Invitrogen) and Hoechst 33258 (DOJINDO) were used for visualization. Immunofluorescence signals were detected by BZ-9000 (KEYENCE). HE staining and immunohistochemistry. Samples were fixed with 4% paraformaldehyde overnight at room temperature and embedded in paraffin using Spin Tissue Processor STP120-2 (Thermo Scientific). Sections were stained with haematoxylin and eosin (HE). For immunohistochemistry, sections were treated with xylene and 100% ethanol, then washed with water followed by treatment with Histofine (Nichirei). After rinsing with PBS, sections were incubated with anti-GFP antibody (Abcam, ab183734; dilution 1:200) or anti-E-cadherin antibody (CST, 24E10, #3195S; dilution 1:400) overnight at 4 °C. Sections were then rinsed with PBS and incubated with Histofine Simple Stain Mouse MAX PO (Nichirei) containing secondary antibody for 30 min at room temperature. DAB Substrate Kit (Nichirei) was used for detection. Microarray. Microarray analysis was performed using the Mouse Gene 1.0 ST Array (Affymetrix) in accordance with the manufacturer's instructions. Data were analysed using the GeneSpring GX software program (version 13; Agilent Technology). Bisulfite sequencing. 200 ng of DNA was bisulfite-treated using EZ DNA Methylation-Gold Kit (ZYMO RESEARCH) according to the supplier's instruction. PCR was performed with LA Taq HS (Takara). PCR products were cloned into pCR4-TOPO vector (Invitrogen). Subcloned colonies were sequenced with a M13 reverse primer by ABI 3500xL (Applied Biosystems). The primers used were: Peg10 DMR forward: GTAAAGTGATTGGTTTTGTATTTTTAAGTG; Peg10 DMR reverse: TTAATTACTCTCCTACAACTTTCCAAATT; Nespas-Gnasxl DMR forward: GGTTTTGGGTTTTAGTTTTTGATTATTTA; and Nespas-Gnasxl DMR reverse: TCTTCTAAAAATCCACTAATCTCACTACC; Snrpn DMR forward: AATTTGTGTGATGTTTGTAATTATTTGG; and Snrpn DMR reverse: ATAAAATACACTTTCACTACTAAAATCCACAA. Allelic expression analysis. A SNP (MSM/Ms: A, 129/SvJ: C) at exon1 of Peg10 was used to distinguish parental alleles. cDNA was amplified using KOD-PlusNeo (TOYOBO). Amplified products were cloned into pCR4-TOPO-Blunt vector (Invitrogen). Subcloned colonies were sequenced with a forward primer by ABI 3500xL. The primers were: Peg10 forward: TGGTTCCTCCAACTGCCCG; and Peg10 reverse: GGCGAATTCTTGGAGGCTTTCG. Library preparation for whole-genome bisulfite sequencing (WGBS). 500 ng of DNA calculated by Qubit was fragmented by sonication (Covaris) and ligated with methylated adapters supplied by TruSeq DNA, Sample Prep Kit-v2 (Illumina). Subsequently, DNA was bisulfite-treated using EZ DNA Methylation-Gold Kit.
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Final library amplification was performed using Pfu Turbo Cx (Agilent Technologies). Sequencing libraries were assessed by Bioanalyzer (Agilent Technologies) and quantified with KAPA Library Quantification Kits (KAPA BIOSYSTEMS). The libraries were then sequenced on HiSeq 2500 (2 × 100 bp or 2 × 101 bp paired-end reads, Illumina) or on NextSeq500 (75 bp single, Illumina). Library preparation for target-captured bisulfite sequencing. 3 μ g of DNA calculated by Qubit was fragmented by sonication. Subsequently, library preparation was performed with SureSelect XT Mouse Methyl-Seq Reagent Kit (Agilent Technologies). The Methyl-Seq Kit could enrich 109 Mb of mouse genomic regions including CpG islands, Gencode promoters, DNase I hypersensitive sites and tissue-specific DMRs. DNA was bisulfite-treated using EZ DNA MethylationGold Kit. Sequencing libraries were assessed by Bioanalyzer and quantified with KAPA Library Quantification Kits. The libraries were then sequenced on HiSeq 2500 (2 × 100 bp or 2 × 101 bp paired-end reads, Illumina). Library preparation for RNA sequencing. 200 ng of total RNA was prepared for library construction. High-quality RNA (RNA integrity number value ≥ 8) assessed by Bioanalyzer was used for library preparation. RNA-seq libraries were generated using Truseq Stranded mRNA LT sample prep kit (Illumina). Poly(A)-containing mRNA was purified by poly(T)-oligo-attached magnetic beads and the RNA was fragmented and primed for cDNA synthesis. Cleaved RNA fragments were reverse transcribed into first strand cDNA using transcriptase and random primers. Second strand cDNA was synthesized by the incorporation of dUTP and double-stranded cDNA was separated using AMPure XP beads (Beckman Coulter). A single ' A' nucleotide was added to the 3′ ends of the blunt fragments and then adapters with index were ligated to the ends of the double-stranded cDNA. Double-stranded cDNA fragments were amplified by PCR with PCR primer Cocktail. The number of PCR cycles was minimized (11-15 cycles) to avoid skewing the representation of the libraries. RNA-seq libraries were sequenced on NextSeq500 (75 bp single, Illumina). DNA methylation data analyses. For allelic methylation analyses, the SNPs data for MSM/Ms were obtained from NIG Mouse Genome Database (MSMv4HQ, http://molossinus.lab.nig.ac.jp/msmdb/index.jsp) and MSM/Ms mouse genome was reconstructed from mm10 using the SNPs. The information about indels was not used in this study. The bases with low quality scores and the adapters in all the sequenced reads were trimmed with cutadapt 1.9.1 34 . The trimmed reads were mapped to both B6 mouse genome (mm10) and MSM/Ms mouse genome independently by Bismark software v.0.15.0 35 with bowtie2 (version 2.2.8) 36 . The reads mapped to the same chromosome and positions of both B6 and MSM/Ms genomes with high mapping quality (MAPQ ≥ 20) were used for further analyses. The B6-derived and MSM/Ms-derived sequenced reads were determined based on the MSM/Ms SNPs data. Y chromosome and M chromosome were omitted from MSM/Ms reference genome because of the lack of the SNPs data. SNPs in CpG sites were excluded and the patterns of bisulfite conversion were taken into account in the determination of parental alleles. Methylated cytosines were extracted from the reads by the Bismark methylation extractor with -ignore 10 -ignore_r2 10 -ignore_3prime 5 -ignore_3prime_r2 5. Because probe sequences of the SureSelect XT were designed for original top strand, only the original bottom (OB) data were used for the analysis. For normal WGBS analysis, the trimmed reads were mapped to the mouse genome (mm10) by Bismark software v.0.15.0 with bowtie2 (version 2.2.8) and default settings, and the mapped reads with high mapping quality (MAPQ ≥ 20) were used for extraction of methylated cytosines by the Bismark methylation extractor with -ignore 10 -ignore_3prime 5 options (single-end reads) or with -ignore 10 -ignore_r2 10 -ignore_3prime 5 -ignore_3prime_r2 5 options (paired-end reads). R (v.3.1) and Integrative Genomics Viewer (IGV) 37 were used to visualize the CpG methylated status. UCSC LiftOver tools 38 (http://genome.ucsc.edu/) were used to convert the coordinates of mm9 assembly into those of mm10 assembly. In the dot plots, each dot represents the methylation percentage for a CpG site at ≥ 5× coverage. CpG sites at ≥ 5× coverage in all samples were captured by heat maps. Genomic locations for each genetic element were described previously [39] [40] [41] . RNA-seq data analyses. The sequenced reads were mapped to the mouse reference genome (mm10) using tophat 2.1.0 42 with the GENCODE version M9 annotation gtf file and the aligner Bowtie2 2.2.5 36 after trimming adaptor sequences and low-quality bases by cutadapt 1.9.1 34 . For allelic expression analysis, the trimmed reads were also mapped to MSM genomes used in the DNA methylation data analyses section, and the reads mapped to the same chromosome and positions of both B6 and MSM/Ms genomes with high mapping quality (MAPQ ≥ 20) were used for further analyses. The expression level of each gene was calculated as reads per kilobase per million mapped reads (RPKM) by cufflinks 2.2.1 43 . The target genes of Mek and Gsk3β were obtained from a previous study 27 . SNPs data for MSM/Ms were obtained as described in the DNA methylation data analyses section. Hierarchical clustering analysis and principal component analysis (PCA) were performed using R (v.3.3.1).
Array comparative genomic hybridization (aCGH). aCGH was performed using SureTag DNA Labelling Kit (Agilent Technologies). 500 ng of DNA measured by Qubit was used for sample labelling. Random primer containing DNA was incubated at 95 °C for 10 min (without restriction digestion). Labelling reactions were performed at 37 °C for 2 h with Cy3 (for reference samples) and Cy5 (for experimental samples). Labelled DNA samples were purified using reaction purification columns provided by SureTag DNA Labelling Kit. 8 × 60K aCGH Microarray was used for the hybridization. Hybridization master mix was denatured at 95 °C for 3 min exactly and then transferred to 37 °C for 30 min. The solutions were centrifuged for 1 min at 6,000g to collect the sample at the bottom of the tube. These mixtures were then hybridized to the Microarray at 65 °C for 24 h in a rotator rack. Microarray was washed using oligo aCGH wash buffer 1 and oligo aCGH wash buffer 2. Microarray Scanning was performed with Agilent C Scanner (Agilent Technologies). Data were extracted using Feature Extraction Software (Agilent Technologies). Data analyses were performed using Agilent Genomic Workbench 7.0 (Agilent Technologies). Teratoma formation. 2i/L ES cells were trypsinized for single-cell suspension and 1 × 10 6 cells were injected subcutaneously into BALB/cSlc-nu/nu mice. At three weeks after the transplantation, formed teratomas were processed for HE staining. Knockout using CRISPR-Cas9. sgRNA was designed using CRISPR DESIGN (http://crispr.mit.edu/). pX330-U6-Chimeric_BB-CBh-hSpCas9 was a gift from F. Zhang (Addgene plasmid no. 42230) 44 . sgRNA was ligated with px330-PGKpuro-pA. 2.5 μ g of the plasmid was transfected using Xfect mES cell Transfection Reagent. Transfected cells were selected using 1 μ g ml −1 puromycin (Sigma) for 2 days. After the selection, colonies were picked up and expanded. Each knockout 2i/L ES cells line was established after evaluation by Sanger sequencing. sgRNA sequences were: Dnmt3a: ACCGCCTCCTGCATGATGCG; Dnmt3b: AATGCACTCCTCATACCCGC; Dnmt3l: GCAGTATGCGCTGCCTCGCC; Dnmt1: CCCGTTGGCGGGACAACCGT; and Scml2: ATCCAGTCGTAGAC GTAACC. In vitro growth assay upon induction of differentiation. Wild type and Dnmtknockout 2i/L ES cell lines were harvested into 6-well plates at a density of 5 × 10 4 cells per well (Day 0). To induce differentiation, PD0325901, CHIR99021 and LIF were removed from the medium, and cells were cultivated for 6 days. The number of cells was calculated at Day 2, 4 and 6 using automatic cell counter TC10 (BioRad). The experiment was performed in triplicate, and each sample was calculated twice. Chimaera formation. Female ICR mice were treated with pregnant mare serum gonadotropin (PMSG; 7.5 IU) and human chorionic gonadotropin (hCG; 7.5 IU) by intraperitoneal (i.p.) injection. Embryos were rinsed with M2 medium (Sigma) and cultured in KSOM medium until the development into blastocysts. ES cells were trypsinized and 7-8 cells per embryo were injected into the blastocoels of E3.5 blastocysts. Injected blastocysts were transferred into the uteri of pseudo-pregnant ICR mice. Fully Automated Fluorescence Stereo Microscope Leica M205 FA (Leica MICROSYSTEMS) was used for the observation of GFP-labelled embryos. Cdx2-mediated trophectoderm (TE) differentiation of ES cells. TE differentiation of ES cells was induced by Cdx2 overexpression as described previously 26 . Doxycycline (Dox)-inducible PB vector containing tetO-Cdx2-IRES-mCherry-EF1-rtTA-IRES-Neo (PB-Cdx2) was generated by Gateway Cloning (Invitrogen) 33 . 2.5 μ g of PB-Cdx2 and 2.5 μ g of transposase were transfected using Xfect mES cell Transfection Reagent. Cells were cultured in GMEM (GIBCO) with 2 μ g ml −1 Dox (Sigma), 350 μ g ml −1 G418, NEAA, P/S and 10% FBS, 100 × sodium pyruvate (GIBCO), 0.11 mM β -mercaptoethanol, 2 μ g ml −1 heparin sodium salt from porcine intestinal mucosa (Sigma), and 20 ng ml −1 recombinant human fibroblast growth factor 4 (Sigma) on feeders. TSC-like colonies were counted at day 7-8 after the transfection. Images for the counting were taken by BioStation CT (Nikon). Overexpression of Uhrf1 in female ES cells. Dox-inducible PB vector containing tetO-Uhrf1-IRES-mCherry-EF1-rtTA-IRES-Neo (PB-Uhrf1) was generated by Gateway Cloning 33 . 2.5 μ g of PB-Uhrf1 and 2.5 μ g of transposase were transfected into female S/L ES cells (p4) using Xfect mES cell Transfection Reagent. Cells were cultured in medium containing 2 μ g ml −1 Dox, and 350 μ g ml −1 G418. Tetraploid embryo complementation. Blastocyst injections were performed using B 6 D 2 F 2 host embryos. Female B 6 D 2 F 1 mice were treated with PMSG (7.5 IU) and hCG (7.5 IU) by i.p. injection. To obtain tetraploid (4n) embryos, electrofusion was performed at 42-46 h post-hCG using ECM2001 Electro Cell Manipulator (BTX). Fused embryos were cultured in KSOM until they developed blastocysts. ES cells were trypsinized and 10-12 cells per each embryo were injected into blastocoels of E3.5 4n blastocysts. Injected 4n blastocysts were transferred into the uteri of pseudo-pregnant ICR mice. Pups were recovered at E19.5 by caesarean section and fostered to lactating ICR mothers. SSLP assay. Strain-specific primers (D1Mit303 for 129/MSM and D2Mit102 for 129/C57BL6) were used to detect the host cell's genome. The primers used were: D1Mit303 forward: GGTTTCTATTTCGGTTCTCGG; D1Mit303 reverse: TCTG Letter reSeArCH TGCTGCAAAACAGAGG; D2Mit102 forward: TTCCCTGTCACTCCTCCC; and D2Mit102 reverse: TGTCTTTATGCTCAGACATACACA. As controls, the DNA of injected ES cells and host TTFs were used. Nuclear transfer. Mature oocytes were collected from the oviducts of B 6 D 2 F 1 female mice following PMSG and hCG by i.p. injection. Nuclear transfer was performed as described previously 23, 45 . Briefly, the MII chromosome-spindle complex was aspirated into the pipette with a minimum volume of ooplasm under a droplet of H-CZB containing 5 mg ml −1 cytochalasin B. Each ES-cell-derived nucleus was injected into an enucleated oocyte. The reconstructed oocytes were activated using 10 mM SrCl 2 in Ca 2+ -free CZB medium in the presence of 5 μ M latrunculin A for 6 h 46, 47 . Pseudo-pronuclear formation was examined, and the oocytes were cultured in CZB until embryo transfer at the two-cell stage. After the cloned embryos had developed to the two-cell stage the next day, they were transferred into the oviducts of pseudo-pregnant ICR strain female mice at 0.5 days post coitum (d.p.c.). At 19.5 d.p.c., the offspring were delivered by caesarean section except 10.5 d.p.c. embryo recovery. Data availability. All data analysed by microarray, WGBS, methyl-seq and RNAseq have been deposited in the Gene Expression Omnibus (GEO) under accession number GSE84165. GSE84165 is composed of the following two subseries, GSE82313 for microarray data and GSE84164 for DNA methylation and RNAseq data. 

